| 标题 |
Daratumumab Plus Lenalidomide and Dexamethasone (D-Rd) Versus Lenalidomide and Dexamethasone (Rd) Alone in Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma (NDMM): Updated Analysis of the Phase 3 Maia Study |
| 网址 | |
| DOI |
10.1182/blood-2022-163335
doi
|
| 其它 |
期刊:Blood 作者:Shaji K Kumar; Philippe Moreau; Nizar Jacques Bahlis; Thierry Facon; Torben Plesner; et al 出版日期:2022-11-15 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)